Clinical Trial Update: Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of radiation therapy, chemotherapy, and bevacizumab for recurrent, unresectable, or stage III/IV non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Northwestern University | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED